Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vanda Pharmaceuticals

4.79
-0.0300-0.62%
Volume:13.58K
Turnover:65.40K
Market Cap:279.33M
PE:-14.52
High:4.87
Open:4.82
Low:4.78
Close:4.82
Loading ...

Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal From Cycle Group Holdings Ltd.

THOMSON REUTERS
·
14 Oct 2024

Vanda Pharmaceuticals Inc - Board Has Determined That Latest Proposal Is Not in Best Interests of Company or Stockholders

THOMSON REUTERS
·
14 Oct 2024

Press Release: Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd.

Dow Jones
·
14 Oct 2024

Cycle Pharma maintains takeover offer for Vanda Pharmaceuticals

Reuters
·
14 Oct 2024

Vanda Shares Climb on Reiterated Cycle Acquisition Offer

Dow Jones
·
14 Oct 2024

BUZZ-Vanda jumps as Cycle Pharma reaffirms buyout offer

Reuters
·
14 Oct 2024

BRIEF-Cycle Pharmaceuticals Reaffirms All-Cash Proposal To Acquire Vanda Pharmaceuticals For $8.00 Per Share

Reuters
·
14 Oct 2024

Cycle Pharmaceuticals: Vanda's Board and Management Team Have Refused to Engage With US

THOMSON REUTERS
·
14 Oct 2024

Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 per Share

THOMSON REUTERS
·
14 Oct 2024

MEDIA-Cycle Pharma is said to stand by $488 mln offer for Vanda - Bloomberg News

Reuters
·
14 Oct 2024

Cycle Pharma Is Said to Stand By $488 Million Offer for Vanda

Bloomberg
·
14 Oct 2024

Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More

Zacks
·
27 Sep 2024

VNDA Stock Down as FDA Rejects NDA for Tradipitant in Gastroparesis

Zacks
·
20 Sep 2024

Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today

Motley Fool
·
20 Sep 2024

Vanda Pharmaceuticals Shares Down 9% After US FDA Declines to Approve Co's Stomach Paralysis Drug

THOMSON REUTERS
·
19 Sep 2024

Vanda Pharma Shares Fall 15% as FDA Denies Approval of Tradipitant NDA for Treating Gastroparesis Symptoms

MT Newswires Live
·
19 Sep 2024